According to GlobalData’s medical device pipeline database, 157 Coronary Stents devices are in various stages of development globally. GlobalData’s report Coronary Stents provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 60 are in active development, while the remaining 101 are in an inactive stage of development. There are 29 products in the early stages of development, and the remaining 31 are in the late stages of development.
A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents. Coronary stent system consists of a stent and balloon catheter delivery system. One unit of coronary stent refers to one unit of coronary stent system.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Coronary Stents pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Coronary Stents devices. Overall, most of these Coronary Stents pipeline devices are being developed by private entities.
Key players involved in the active development of Coronary Stents include Abbott Vascular, Advanced Bifurcation Systems, Amaranth Medical, MicroPort Scientific, MIV Therapeutics, Cordis US, Cardionovum, Boston Scientific, Xenogenics and Biotronik.
For a complete picture of the developmental pipeline for Coronary Stents devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
